CG Oncology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	33.7	32.49	257.07	8.27	88.14	88.14
Short-Term Investments	1,043	709.67	484.93	179.41	55.34	55.34
Cash & Short-Term Investments	1,076	742.16	742	187.67	143.48	143.48
Cash Growth	56.33%	0.02%	295.37%	30.80%	-	-
Accounts Receivable	1.28	0.69	-	-	-	-
Other Receivables	-	-	-	0.09	0.3	0.3
Total Trade Receivables	1.28	0.69	-	0.09	0.3	0.3
Inventory	1.49	1.57	-	-	-	-
Other Current Assets	23.13	15.07	12.21	6.36	3.42	3.42
Total Current Assets	1,102	759.48	754.21	194.12	147.21	147.21
Net Property, Plant & Equipment	19.59	19.57	0.49	0.49	0.51	0.51
Other Intangible Assets	0.56	0.58	-	-	-	-
Goodwill	10.3	10.3	-	-	-	-
Other Long-Term Assets	2.68	1.68	0.09	4.69	0.03	0.03
Total Assets	1,135	791.59	754.8	199.3	147.75	147.75
Accounts Payable	8.24	5.71	6.52	3.24	0.99	0.99
Accrued Expenses	25.91	24.21	14.67	10.44	5.29	5.29
Current Portion of Long-Term Debt	-	-	-	-	8.97	8.97
Current Portion of Leases	1.07	0.92	0.19	0.22	0.19	0.19
Other Current Liabilities	-	-	-	0.35	-	-
Total Current Liabilities	35.22	30.84	21.37	14.25	15.43	15.43
Long-Term Debt	3	3	-	-	6.53	6.53
Long-Term Leases	3.51	3.11	0.05	0.24	0.26	0.26
Other Long-Term Liabilities	1.76	2.05	-	0.01	0.35	0.35
Total Long-Term Liabilities	8.27	8.15	0.05	0.26	7.14	7.14
Total Liabilities	43.48	38.99	21.42	14.51	22.57	22.57
Additional Paid-in Capital	1,531	1,132	951.35	6.84	3.64	3.64
Retained Earnings	-439.18	-378.98	-217.98	-129.94	-81.34	-81.34
Total Common Shareholders' Equity	1,092	752.6	733.38	-123.1	-77.69	-77.69
Minority Interest	-	-	-	307.89	202.87	82.87
Shareholders' Equity	1,092	752.6	733.38	184.79	125.18	5.18
Total Liabilities & Equity	1,135	791.59	754.8	199.3	147.75	147.75
Total Debt	7.58	7.02	0.24	0.46	15.94	15.94
Net Cash (Debt)	1,069	735.13	741.76	187.21	127.54	127.54
Net Cash Growth	45.37%	-0.89%	296.21%	46.79%	-	-
Net Cash Per Share	13.46	9.51	11.87	43.23	34.09	0.04
Book Value	1,092	752.6	733.38	-123.1	-77.69	-77.69
Book Value Per Share	13.75	9.74	11.73	-28.42	-20.77	-0.02
Tangible Book Value	1,081	741.73	733.38	-123.1	-77.69	-77.69
Tangible Book Value Per Share	13.62	9.60	11.73	-28.42	-20.77	-0.02

Updated May 8, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q